Literature DB >> 16721053

Spreading the signal: dissociation of Chk1 from chromatin.

Veronique A J Smits1.   

Abstract

The effector kinase Chk1 plays a critical role in the DNA damage checkpoint response by phosphorylating regulators of the cell cycle machinery, resulting in an inhibition of cell cycle progression. In the presence of genotoxic stress, the PI3 kinase-like kinase ATR rapidly phosphorylates Chk1 on conserved serine residues, thereby triggering kinase activation through the release of an auto-inhibitory region present at its C-terminus and by regulating interactions with other proteins. Recent data have demonstrated an additional regulatory mechanism of Chk1 functioning: Chk1 binds chromatin in unperturbed cells and dissociates from chromatin in response to DNA damage in a manner that is dependent on PIKK-mediated phosphorylation. Here, I give an overview of these findings and discuss the implications of these data for our understanding of the execution of the checkpoint arrest induced after the detection of DNA damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16721053     DOI: 10.4161/cc.5.10.2761

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

1.  VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling.

Authors:  Sandrine Passemard; Vincent El Ghouzzi; Hala Nasser; Catherine Verney; Guilan Vodjdani; Adrien Lacaud; Sophie Lebon; Marc Laburthe; Patrick Robberecht; Jeannette Nardelli; Shyamala Mani; Alain Verloes; Pierre Gressens; Vincent Lelièvre
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

2.  USP7 controls Chk1 protein stability by direct deubiquitination.

Authors:  Ignacio Alonso-de Vega; Yusé Martín; Veronique A J Smits
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

3.  UNC45A localizes to centrosomes and regulates cancer cell proliferation through ChK1 activation.

Authors:  Yasmeen Jilani; Su Lu; Huang Lei; Larry M Karnitz; Ahmed Chadli
Journal:  Cancer Lett       Date:  2014-11-10       Impact factor: 8.679

4.  Differential Dynamics of ATR-Mediated Checkpoint Regulators.

Authors:  Daniël O Warmerdam; Roland Kanaar; Veronique A J Smits
Journal:  J Nucleic Acids       Date:  2010-08-17

Review 5.  The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design.

Authors:  Ruth Thompson; Alan Eastman
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

6.  Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control.

Authors:  Deborah Wilsker; Eva Petermann; Thomas Helleday; Fred Bunz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-17       Impact factor: 11.205

7.  Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing.

Authors:  John C Reader; Thomas P Matthews; Suki Klair; Kwai-Ming J Cheung; Jane Scanlon; Nicolas Proisy; Glynn Addison; John Ellard; Nelly Piton; Suzanne Taylor; Michael Cherry; Martin Fisher; Kathy Boxall; Samantha Burns; Michael I Walton; Isaac M Westwood; Angela Hayes; Paul Eve; Melanie Valenti; Alexis de Haven Brandon; Gary Box; Rob L M van Montfort; David H Williams; G Wynne Aherne; Florence I Raynaud; Suzanne A Eccles; Michelle D Garrett; Ian Collins
Journal:  J Med Chem       Date:  2011-11-23       Impact factor: 7.446

8.  Chk1 Promotes DNA Damage Response Bypass following Oxidative Stress in a Model of Hydrogen Peroxide-Associated Ulcerative Colitis through JNK Inactivation and Chromatin Binding.

Authors:  Kathrin Reissig; Andrew Silver; Roland Hartig; Antje Schinlauer; Diana Walluscheck; Thomas Guenther; Sandra Siedentopf; Jochen Ross; Diep-Khanh Vo; Albert Roessner; Angela Poehlmann-Nitsche
Journal:  Oxid Med Cell Longev       Date:  2017-06-07       Impact factor: 6.543

9.  Site-specific phosphorylation of the DNA damage response mediator rad9 by cyclin-dependent kinases regulates activation of checkpoint kinase 1.

Authors:  Carla Manuela Abreu; Ramesh Kumar; Danielle Hamilton; Andrew William Dawdy; Kevin Creavin; Sarah Eivers; Karen Finn; Jeremy Lynn Balsbaugh; Rosemary O'Connor; Patrick A Kiely; Jeffrey Shabanowitz; Donald F Hunt; Muriel Grenon; Noel Francis Lowndes
Journal:  PLoS Genet       Date:  2013-04-04       Impact factor: 5.917

10.  UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.

Authors:  Jingyuan Sun; Zhenru Zhu; Wenwen Li; Mengying Shen; Chuanhui Cao; Qingcan Sun; Zeqin Guo; Li Liu; Dehua Wu
Journal:  J Exp Clin Cancer Res       Date:  2020-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.